Pelthos Therapeutics Inc. PTHS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -70.5%— | -65.8%— | -36.7%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.4×— | 0.3×— | 0.1×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 2.8×+2.6× | 2.1×+1.7× | 2×+1.4× | 0.1×— | 0.2×— | |
| Quick ratio | 1.9×+1.7× | 1.1×+0.8× | 1×+0.4× | 0.1×— | 0.2×— | |
| Cash ratio | 1.3×+1.3× | 0.7×+0.6× | 0.6×+0.2× | 0×— | 0×— | |
| Leverage | ||||||
| Interest coverage | -8.4×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pelthos Therapeutics Inc.'s profit margins?
- Pelthos Therapeutics Inc. (PTHS) runs a 79.6% gross margin and a -157.7% operating margin, with a -186.2% net margin.
- Where do Pelthos Therapeutics Inc.'s ratios come from?
- Every ratio is computed from Pelthos Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
